- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05050266
Verbetering van de mentale en fysieke gezondheid van vrouwelijke veteranen (EMPOWER)
Verbetering van de mentale en fysieke gezondheid van vrouwen door betrokkenheid en behoud (EMPOWER) QUERI 2.0 (QUE 20-028)
Women Veterans are the fastest growing segment of VA users. This dramatic growth has created challenges for VA to ensure that appropriate services are available to meet women Veterans' needs, and that they will want and be able to use those services. The EMPOWER QUERI 2.0 Program is a cluster randomized type 3 hybrid implementation-effectiveness trial testing two strategies designed to support implementation and sustainment of evidence-based practices for women Veterans in at least 20 VA facilities from 4 regions.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Women Veterans are the fastest-growing segment of users in the Veterans Health Administration (VA). Their numbers are projected to increase by 73%, from 9.3% to 16.4%, between 2015 and 2043. Despite VA investment in improving care for women Veterans, gender disparities persist in cardiovascular (CV) and diabetes risk factor control. Also, the rate of perinatal depression among women Veterans is higher than that among civilian women, which is of particular concern given the association between perinatal depression and suicidality. Barriers to care for women Veterans include distance to VA care, rurality, competing work and caregiving responsibilities, comorbid mental health issues, and harassment on VA grounds. Improvements are still needed to increase women Veterans' access to and engagement in convenient, safe, evidence-based, patient-centered care that achieves the VA "lane of effort" of Veterans' "lifelong health, well-being, and resilience."
Since its inception in 2015, the Enhancing Mental and Physical health of Women through Engagement and Retention (EMPOWER) QUERI 1.0 team has focused on implementing gender-tailored care models for women Veteran patients. In EMPOWER 1.0 studies, women expressed preferences for gender-specific (women only) care and for virtual care options. Therefore, the EMPOWER 2.0 Impact Goal is to expand access to virtual, evidence-based, preventive lifestyle and mental health services for women Veterans with high-priority health conditions in rural and urban-isolation areas. This cluster randomized type 3 hybrid implementation-effectiveness trial randomized 20 VA sites to one of two implementation strategies, the Replicating Effective Practices (REP) or Evidence-Based Quality Improvement (EBQI), to support implementation and sustainment of evidence-based practices (EBPs). The EBPs focus on preventive lifestyle and mental health care for women Veterans across VA facilities, several of which are rural, low-performing in women's health care, and/or lead sites for high reliability organization. The study team will conduct a mixed methods implementation evaluation to compare the effectiveness of REP and EBQI in terms of: (a) improved access to and rates of engagement in virtual preventive lifestyle and mental health services and improved VA performance metrics for virtual and telehealth care delivery and related clinical outcomes for women Veterans; (b) progression along the Stages of Implementation Completion; (c) adaptation, sense-making, and experiences of EBP implementation among multilevel stakeholders; and (d) cost and return on investment.
On 8/15/23, as part of our 12 month registration update corrected the primary outcomes to accurately reflect the randomized trial and analyses design. The cluster randomized trial will evaluate the effectiveness of two implementation strategies (REP and EBQI) in implementing evidence-based practices (EBPs) for preventive services. Although we are implementing three evidence-based practices (DPP, TLC and ROSE), the EBPs are combined for each of the trial's two primary outcomes (access and engagement).
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
California
-
West Los Angeles, California, Verenigde Staten, 90073-1003
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
This study is recruiting VA sites - not individual patients. Prior to randomization, the study team will work with sites to ensure they have met the preconditions necessary to enroll in the study, which includes VISN, regional and/or facility level leadership support for participation.
Exclusion Criteria:
N/A
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: REP
Replicating Effective Practices (REP) is a lower-intensity implementation strategy with explicit process framework for local tailoring |
The REP framework consists of 4 phases: pre-conditions, pre-implementation, implementation and maintenance/evolution. REP has a strong evidence-base and application in VHA health services research in promoting uptake of EBPs. Sites randomized to REP will meet quarterly with the implementation support team (i.e., low-intensity). |
|
Experimenteel: EBQI
Evidence-Based Quality Improvement (EBQI) is a higher-intensity implementation strategy that entails external facilitation and formal training in quality improvement. |
EBQI is a systematic quality improvement method for engaging frontline practices in improvement that introduces "best science" and evidence in the service of operational goals. EBQI has been tested in several VA implementation trials. Sites randomized to EBQI will meet monthly with the implementation support team (i.e., high-intensity). |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Access to virtual care for preventive services
Tijdsspanne: 12 months
|
Proportion of eligible women Veterans who enroll in virtual DPP, TLC, or ROSE at each site |
12 months
|
|
Engagement in virtual care for preventive services
Tijdsspanne: 12 months
|
Proportion of eligible women Veterans who attend 1 or more virtual DPP, TLC, or ROSE sessions at each site |
12 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Participation and engagement: DPP
Tijdsspanne: 6 and 12 months
|
average # of sessions attended by women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: DPP
Tijdsspanne: 6 and 12 months
|
proportion who completed >9 and >16 sessions among women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: DPP
Tijdsspanne: 6 and 12 months
|
% weight change among women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: TLC
Tijdsspanne: 6 months
|
average # of TLC sessions completed among women Veterans who enrolled in TLC at each site |
6 months
|
|
Participation and engagement: TLC
Tijdsspanne: 6 months
|
% with health behavioral goal among women Veterans who enrolled in TLC at each site |
6 months
|
|
Participation and engagement: TLC
Tijdsspanne: 6 months
|
% with behavioral change (physical activity, diet: fruit, vegetable and sugary beverage intake, stress and coping, and weight) at each site |
6 months
|
|
Participation and engagement: ROSE
Tijdsspanne: 6 months
|
average # of ROSE sessions completed at each site |
6 months
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Alison B Hamilton, PhD MPH, VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Publicaties en nuttige links
Algemene publicaties
- Finley EP, Hamilton AB, Canelo I, Jackson SS, Lesser R, Oberman RS, Yosef J, Chrystal JG, Fletcher EH, Bean-Mayberry B, Moin T, Farmer MM, Lang AJ. Collaborative tailoring of the Reach Out, Stay Strong Essentials (ROSE) program for pregnant veterans in the U.S. Veterans Health Administration: a qualitative case study of contextual conditions and adaptations. BMC Health Serv Res. 2025 May 23;25(1):746. doi: 10.1186/s12913-025-12871-x.
- Malone A, Clair K, Chanfreau C, Bean-Mayberry B, Oberman R, Lesser R, Knight C, Finley E, Hamilton A, Farmer MM, Moin T. Predictors of enrollment in a virtual diabetes prevention program among women veterans: a retrospective analysis. BMC Womens Health. 2024 Aug 24;24(1):465. doi: 10.1186/s12905-024-03314-6.
- Finley EP, Chrystal JG, Gable AR, Fletcher EH, Palma A, Canelo I, Oberman RS, Jackson SS, Lesser R, Moin T, Bean-Mayberry B, Farmer MM, Hamilton A. The Rapid Implementation Feedback (RIF) report: real-time synthesis of qualitative data for proactive implementation planning and tailoring. Implement Sci Commun. 2024 Jun 21;5(1):69. doi: 10.1186/s43058-024-00605-9.
- Hamilton AB, Finley EP, Bean-Mayberry B, Lang A, Haskell SG, Moin T, Farmer MM; EMPOWER QUERI Team. Enhancing Mental and Physical Health of Women through Engagement and Retention (EMPOWER) 2.0 QUERI: study protocol for a cluster-randomized hybrid type 3 effectiveness-implementation trial. Implement Sci Commun. 2023 Mar 8;4(1):23. doi: 10.1186/s43058-022-00389-w.
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
- Depressie
- Obesitas
- Mentale gezondheid
- Cholesterol
- Hypertensie
- Vrouwen
- Suikerziekte
- Zwangerschap
- Roken
- Overgewicht
- Veteranen
- Basisgezondheidszorg
- Preventie
- Hart-en vaatziekten
- Voorkeur van de patiënt
- Patiëntparticipatie
- Gezondheidsgedrag
- Kwaliteitsverbetering
- Tevredenheid van de patiënt
- Prediabetische toestand
- Artsen, Eerstelijnszorg
- Risicofactoren voor hartziekten
- Depressie, postpartum
- Artsen, vrouwen
Aanvullende relevante MeSH-voorwaarden
- Urogenitale ziekten
- Endocriene systeemziekten
- Vaatziekten
- Psychische aandoening
- Voedingsstoornissen
- Vrouwelijke urogenitale ziekten en zwangerschapscomplicaties
- Metabole ziekten
- Overvoeding
- Lichaamsgewicht
- Zwangerschap Complicaties
- Gedragssymptomen
- Glucosemetabolismestoornissen
- Stemmingsstoornissen
- Puerperale aandoeningen
- Depressieve stoornis
- Pathologische aandoeningen, tekenen en symptomen
- Gedrag
- Voedings- en stofwisselingsziekten
- Tekenen en symptomen
- Therapietrouw en therapietrouw
- Persoonlijke voldoening
- Patiëntacceptatie van gezondheidszorg
- Overgewicht
- Obesitas
- Hypertensie
- Hart-en vaatziekten
- Depressie
- Suikerziekte
- Depressie, postpartum
- Prediabetische toestand
- Geestelijk welzijn
- Roken
- Gezondheidsgedrag
- Patiëntparticipatie
- Voorkeur van de patiënt
- Tevredenheid van de patiënt
Andere studie-ID-nummers
- QUX 21-006
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Data sets underlying all publications resulting from the proposed research will not be shared outside VA, except as required under the Freedom of Information Act (FOIA), because VHA policy would prohibit re-disclosure.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .